Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases

被引:24
作者
Kapoor, Neena [1 ]
Shinagare, Atul B. [1 ]
Jagannathan, Jyothi P. [1 ]
Shah, Shaan H. [1 ]
Krajewski, Katherine M. [1 ]
Hornick, Jason L. [1 ]
Ramaiya, Nikhil H. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Imaging,Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
extraskeletal myxoid chondrosarcoma; CT; MRI; FDG-PET/CT; SMALL PULMONARY ADENOCARCINOMAS; ABNORMALITY; T(9-22)(Q22-Q12);
D O I
10.2478/raon-2014-0005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The aim of the study was to evaluate the clinical and imaging features of extraskeletal myxoid chondrosarcoma (EMC) including initial presentation, recurrence, and metastases. Patients and methods. In this institutional review board-approved retrospective study, imaging features of 13 patients with pathologically proven EMC seen from August 1995 to December 2011 were analyzed. The group included 3 women and 10 men and the mean age was 54 years (range 29-73 years). Imaging studies were evaluated by two radiologists in consensus. Location, size, and imaging features of primary tumors were recorded as well as the presence of recurrent disease and location of metastases. Results. Among 13 patients, 3 died during the timeframe of this study. Nine patients had primary tumor in the lower extremity, and average tumor size was 9.3 cm (range 3.3-18 cm). On MRI, primary tumors were hyperintense on T2, isointense to muscle on T1, and demonstrated peripheral/septal enhancement. Three patients had local recurrence and 12 had metastatic disease, with lung involvement being the most common. Tumor density on contrast enhanced CT ranged from 8.2 to 82.9 Hounsfield unit (HU). FDG-PET/CT imaging was performed in 3 patients. One patient had no FDG avid disease and 2 patients had metastatic disease with standard uptake values (SUV) of 2.8 and 7.4. The patient with intense FDG uptake demonstrated more solid appearing tumor burden and had the shortest survival. Conclusions. EMC is a rare tumor that often occurs in the lower extremities and frequently metastasizes to the lungs. Increased tumor density and increased FDG uptake may be related to more aggressive disease.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 17 条
[1]  
[Anonymous], 2010, CUAJ-CAN UROL ASSOC
[2]   FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients [J].
Brenner, W ;
Conrad, EU ;
Eary, JF .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (02) :189-195
[3]   Extraskeletal myxoid chondrosarcoma of the knee [J].
Gebhardt, MC ;
Parekh, SG ;
Rosenberg, AE ;
Rosenthal, DI .
SKELETAL RADIOLOGY, 1999, 28 (06) :354-358
[4]   TRANSLOCATION-(9-22)(Q22-Q12) - A RECURRENT CHROMOSOME ABNORMALITY IN EXTRASKELETAL MYXOID CHONDROSARCOMA [J].
HIRABAYASHI, Y ;
ISHIDA, T ;
YOSHIDA, MA ;
KOJIMA, T ;
EBIHARA, Y ;
MACHINAMI, R ;
IKEUCHI, T .
CANCER GENETICS AND CYTOGENETICS, 1995, 81 (01) :33-37
[5]   Extraskeletal myxoid chondrosarcoma - A multi-institutional study of 42 cases in Japan [J].
Kawaguchi, S ;
Wada, T ;
Nagoya, S ;
Ikeda, T ;
Isu, K ;
Yamashiro, K ;
Kawai, A ;
Ishii, T ;
Araki, N ;
Myoui, A ;
Matsumoto, S ;
Umeda, T ;
Yoshikawa, H ;
Hasegawa, T .
CANCER, 2003, 97 (05) :1285-1292
[6]   Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas [J].
Kondo, T ;
Yamada, K ;
Noda, K ;
Nakayama, H ;
Kameda, Y .
LUNG CANCER, 2002, 36 (01) :49-57
[7]   Extraskeletal myxoid chondrosarcoma - A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases [J].
Meis-Kindblom, JM ;
Bergh, P ;
Gunterberg, B ;
Kindblom, LG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (06) :636-650
[8]   Extraskeletal myxoid chondrosarcoma arising in the finger [J].
Okamoto, S ;
Hara, K ;
Sumita, S ;
Sato, K ;
Hisaoka, M ;
Aoki, T ;
Hashimoto, H .
SKELETAL RADIOLOGY, 2002, 31 (05) :296-300
[9]   CHROMOSOMAL ABNORMALITY T(9-22)(Q22-Q12) IN AN EXTRASKELETAL MYXOID CHONDROSARCOMA CHARACTERIZED BY FINE NEEDLE ASPIRATION CYTOLOGY, ELECTRON-MICROSCOPY, IMMUNOHISTOCHEMISTRY AND DNA FLOW-CYTOMETRY [J].
ORNDAL, C ;
CARLEN, B ;
AKERMAN, M ;
WILLEN, H ;
MANDAHL, N ;
HEIM, S ;
RYDHOLM, A ;
MITELMAN, F .
CYTOPATHOLOGY, 1991, 2 (05) :261-270
[10]  
Rubin BP, 1999, ADV ANAT PATHOL, V6, P204